Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    Chemotherapy
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    May 19, 2023
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    Special Populations
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    March 10, 2023
    How I Practice Mindfulness as an Oncology Nurse
    Nurse well-being
    How I Practice Mindfulness as an Oncology Nurse
    March 03, 2023
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Safety

    Emotional Coping Strategies for COVID-19
    Clinical practice

    Emotional Coping Strategies for COVID-19

    The COVID-19 novel coronavirus pandemic is turning the world, inside and outside of the hospital, upside down. Not only are oncology nurses seeing high demands at work, but changes and restrictions are being instated at home as well.

    March 16, 2020
    Prescription Drug Proposal; COVID-19 Safety Legislation; Drug Costs Outpace Inflation
    Health Policy

    Prescription Drug Proposal; COVID-19 Safety Legislation; Drug Costs Outpace Inflation

    Drug pricing is a top legislative issue for Congress, and amid rising COVID-19 concerns, health policy topics are more pressing than ever. On March 5, Senator Martha McSally (R-AZ) introduced the Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020, which would allow Medicare to negotiate prices after a drug’s patent expires as well as cap out-of-pocket prescription spending for seniors at $3,100 per year.

    March 16, 2020
    Telehealth Visits During COVID-19
    Clinical practice

    Telehealth Visits During COVID-19

    With the Centers for Disease Control and Prevention’s recommendations for practicing social distancing to slow the national risk of transmission of COVID-19 novel coronavirus, oncology nurses must take increased precautions with patients with cancer who are at increased risk for contracting or experiencing poorer outcomes from COVID-19. Patients require communication and education in these uncertain times.

    March 13, 2020
    FDA Grants Accelerated Approval to Nivolumab and Ipilimumab Combination for Hepatocellular Carcinoma
    U.S. Food and Drug Administration (FDA)

    FDA Grants Accelerated Approval to Nivolumab and Ipilimumab Combination for Hepatocellular Carcinoma

    On March 10, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the combination of nivolumab and ipilimumab (Opdivo® and Yervoy®) for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. 

    March 12, 2020
    BD Issues Class I Recall of Alaris System Infusion Pumps
    U.S. Food and Drug Administration (FDA)

    BD Issues Class I Recall of Alaris System Infusion Pumps

    On February 4, 2020, BD announced a recall of all lots of affected models of its Alaris System pump modules because of multiple system errors, software errors, and use-related errors. On March 6, 2020, the U.S. Food and Drug Administration identified it as a class I recall, its most serious level of recalls, because of the possibility of serious injuries or death.

    March 10, 2020
    Educational Framework Offers Guidance for Oral Chemo Safety at Home
    Safety

    Educational Framework Offers Guidance for Oral Chemo Safety at Home

    One aspect that ambulatory oncology nurses must consider in the greater staffing conversation is the time spent on educating patients and caregivers about oral chemotherapy safety in the home setting. Developing an educational framework to guide those conversations not only ensures that all critical information is covered but also that it’s delivered in a standard and efficient process. 

    March 10, 2020
    Supreme Court ACA Case; Cancer Moonshot; COVID-19 Outbreak
    Health Policy

    Supreme Court ACA Case; Cancer Moonshot; COVID-19 Outbreak

    As part of its focus to dismantle the 2010 healthcare law, the GOP repealed the Affordable Care Act individual mandate in 2017. Republican state attorneys general then challenged the law’s constitutionality in a series of lower court cases, and the most recent has been lingering in federal courts for more than a year. On March 2, the Supreme Court agreed to take up the issue, marking the third time the law will be heard at the highest court in the country.  

    March 09, 2020
    COVID-19 Fact Sheet and Implications for Patients With Cancer
    Clinical practice

    COVID-19 Fact Sheet and Implications for Patients With Cancer

    COVID-19 is a novel coronavirus (a large family of viruses that can cause cold-like illnesses) first identified in December 2019. It is a respiratory illness and can be spread from person to person through respiratory droplets during close contact. The first case of COVID-19 in the United States was reported on January 21, 2020.

    March 04, 2020
    Nurses Can Protect Patients From Neurotoxicity During Lumbar Puncture Procedures
    Clinical practice

    Nurses Can Protect Patients From Neurotoxicity During Lumbar Puncture Procedures

    When cleaning patients’ skin in preparation for lumbar puncture procedures, oncology nurses must consider side effects from use of various germicide solutions. Chlorhexidine gluconate (CHG) solution has been considered the broad-spectrum germicide effective against most nosocomial yeasts and gram-positive and -negative bacteria. It’s available as 2% or 5% CHG in 70% isopropyl alcohol and is used as an antiseptic for skin preparation and central venous catheter dressings.

    January 28, 2020
    B. Braun Recalls Certain Lots of Blood Administration Sets
    Safety

    B. Braun Recalls Certain Lots of Blood Administration Sets

    Because of the potential for leakage at the joint between the blood filters and tubing, B. Braun issued a voluntary recall of 22 lots of its y-type blood administration sets in November 2019. The recalled sets are used to deliver blood from a container to a patient's vascular system through an IV catheter inserted into a vein or central venous catheter.

    December 03, 2019
    Should You Wear a Gown to Disconnect Chemo?
    Safety

    Should You Wear a Gown to Disconnect Chemo?

    The short answer is yes—guidelines from ONS, National Institute of Occupational Safety and Health, Occupational Safety and Health Administration, and U.S. Pharmacopia all call for nurses to always wear appropriate personal protective equipment (PPE) when at risk for exposure, including disconnecting a patient’s chemotherapy. Wearing a gown and other PPE isn’t just good practice—it protects nurses at one of many touchpoints during chemotherapy administration and patient care where healthcare providers are at risk for exposure to hazardous drugs.

    October 21, 2019
    What the Research Says About Drug Interactions and Medical Cannabis
    Oncology drug research

    What the Research Says About Drug Interactions and Medical Cannabis

    Despite medical cannabis’s legalization for medical use throughout 31 different jurisdictions in the United States, practicing providers have little research and few guidelines for patient care. To address the gap, in 2018 the National Council of State Boards of Nursing published Nursing Guidelines for Medical Marijuana, which provides general nursing education and guidance—yet doesn’t discuss drug interactions, specifically. To understand how medical cannabis affects concomitant pharmaceuticals, nurses must have a basic knowledge of the endocannabinoid system (ECS).  

    October 04, 2019
    FDA Warns of Rare Lung Inflammation With Certain CDK 4/6 Inhibitors
    U.S. Food and Drug Administration (FDA)

    FDA Warns of Rare Lung Inflammation With Certain CDK 4/6 Inhibitors

    Palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio) used to treat some patients with advanced breast cancers may cause rare but severe inflammation of the lungs, the U.S. Food and Drug Administration (FDA) announced on September 13, 2019. It approved new warnings about the risk on the prescribing information and package insert for the entire class of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor medicines. However, “the overall benefit of CDK 4/6 inhibitors is still greater than the risks when used as prescribed,” the agency noted.

    September 13, 2019
    Company Recalls TPN Bags Because of Leak and Infection Risk
    Safety

    Company Recalls TPN Bags Because of Leak and Infection Risk

    Bags used to store and administer total parenteral nutrition (TPN) are being recalled because of leaks near the divider rod and channel when the rod is removed, the Metrix Company of Dubuque, IA, announced on September 9, 2019.

    September 10, 2019
    Why Aren’t Nurses Adhering to PPE Requirements?
    Safety

    Why Aren’t Nurses Adhering to PPE Requirements?

    Oncology nurses are dedicated to providing the best, safest cancer care to their patients—protecting them from medical harm and prolonging life. But when it comes to protecting themselves, nurses sometimes take shortcuts in wearing personal protective equipment (PPE) that guards them against exposure to hazardous drugs. 

    September 10, 2019
    Evidence Supports Strategies for Better Safe Handling Practice
    Research

    Evidence Supports Strategies for Better Safe Handling Practice

    The evidence is clear: for more than 40 years, reports have confirmed that hazardous drug exposure poses significant safety risks to providers who handle many agents related to cancer treatments. Healthcare professionals experience several substantial health threats, including reproductive problems, airway and skin irritation, and cancers. Despite the potential health risks, the data are also clear: nurses routinely do not wear personal protective equipment as recommended when handling hazardous drugs.

    September 09, 2019
    Health Care in Campaigns; Respiratory Illness From Vaping; Drug Importation Politics
    Health Policy

    Health Care in Campaigns; Respiratory Illness From Vaping; Drug Importation Politics

    Chicago ONS Chapter member Janice Phillips, RN, CENP, PhD, FAAN, said it all in her op-ed published on Morning Consult. The entire Democratic field of presidential candidates has declared some form of healthcare overhaul, albeit to varying degrees of change. With expanded access and reduced costs for patients and families as a priority, the centerpiece to most presidential hopefuls’ domestic policy program is redesigning a struggling system.

    September 09, 2019
    USP <800> Brings Change, Collaboration to Pharmacy and Nursing
    Safety

    USP <800> Brings Change, Collaboration to Pharmacy and Nursing

    U.S. Pharmacopeia (USP) chapter <800> provides safety measures for all healthcare workers in any setting where hazardous drugs (HDs) are used in the health system. For situations from the initial delivery of the drug to the institution through administration and disposal, USP <800> provides a vast number of safety measures intended to minimize risk and potential exposure to HDs. To meet the new requirements, medical institutions and pharmacies have had to make significant changes in various systems.

    September 03, 2019
    Handle With Care: How USP <800> Will Affect Nursing Practice
    Safe handling

    Handle With Care: How USP <800> Will Affect Nursing Practice

    Police officers wear body armor and construction workers wear hard hats. Why? Because these professions carry inherent dangers in the line of duty­—and oncology nursing does too. Statistically, healthcare workers face more workplace-related dangers than both law enforcement and construction, yet attention to safety and personal protection isn’t always a central focus. This can be especially true in cancer care, where nurses are required to administer hazardous drugs (HDs) and handle dangerous medications on a daily basis. Although safety recommendations exist, few enforceable standards are protecting nurses handling HDs.

    September 03, 2019
    The Case of the Safety Session
    Safety

    The Case of the Safety Session

    Doug is a 48-year-old triathlete who was recently diagnosed with chronic myeloid leukemia (CML) after a routine blood test showed an increase in white blood cells and a subsequent bone marrow biopsy showed greater than 20% blast cells. The medical oncologist prescribed the oral drug dasatinib. Doug and his wife meet with Staci, RN, to receive oral therapy education. During the teaching, Doug says his wife will have no trouble dispensing the dasatinib because she already prepares all of their meals and nutritional supplements.  

    August 20, 2019
    The Case of the Pregnancy Predicament
    Clinical practice

    The Case of the Pregnancy Predicament

    A 33-year-old woman presents to the emergency department with fever, weight loss, and dyspnea. She is five months pregnant. A computed tomography (CT) chest scan without contrast shows a large mediastinal mass. Biopsy demonstrates Hodgkin lymphoma (HL), but magnetic resonance imaging (MRI) of her abdomen and pelvis without contrast is negative for lymphadenopathy. Her echocardiogram and pulmonary function testing are normal.

    August 02, 2019
    Protect Yourself and Your Colleagues From the Dark Side of Caring
    Safety

    Protect Yourself and Your Colleagues From the Dark Side of Caring

    Nursing requires emotional energy and hard work to provide care to those we serve. However, there’s a dark side to the profession: workplace violence, or the exchanges perceived to be offensive or intimidating that can progress as far as homicide.  

    July 30, 2019
    FDA Recalls Textured Breast Implants Because of Lymphoma Risk
    U.S. Food and Drug Administration (FDA)

    FDA Recalls Textured Breast Implants Because of Lymphoma Risk

    On July 24, 2019, the U.S Food and Drug Administration (FDA) requested that Allergan recall its BIOCELL textured breast implants and tissue expanders because of the associated increased risk of breast implant-associated anaplastic large cell lymphoma; Allergan agreed and is removing the products from the global market.

    July 24, 2019
    The Case of the Explicit Exposure
    Clinical practice

    The Case of the Explicit Exposure

    Mr. Larsen presents to the clinic for his first dose of R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone) for a diagnosis of diffuse large B-cell lymphoma. Elizabeth, his oncology nurse, just started the cyclophosphamide when she is paged to the desk for a call from Mr. Larsen’s oncologist. She quickly removes her face shield and gloves as she hurriedly leaves the room to take the call. After completing the call, she returns to Mr. Larsen’s room to remove her gown.  

    July 16, 2019
    Here’s How You Can Confront Workplace Violence in a Healthcare Setting
    Safety

    Here’s How You Can Confront Workplace Violence in a Healthcare Setting

    RNs encounter workplace violence and abuse at a far higher rate than in any other profession in the United States. Although the topic is uncomfortable, it’s a very real aspect of health care for many professionals. Most nurses have likely experienced an abusive, dangerous, or violent encounter in the healthcare setting at some point in their careers.  

    July 05, 2019
    What USP Means for Safe Oncology Nursing Practice
    Safety

    What USP Means for Safe Oncology Nursing Practice

    Nurses in oncology who compound hazardous drugs may be familiar with the U.S. Pharmacopeial Convention (USP) because of chapter <795> related to compounding nonsterile medications and chapter <797> addressing compounding sterile medications. But what is USP really, and why does it have an impact on oncology nursing practice?

    May 07, 2019
    Prevent Important Information From Getting Lost in Translation
    Safety

    Prevent Important Information From Getting Lost in Translation

    At the heart of patient-centered cancer care is communication and understanding, and oncology nurses have a responsibility to ensure that their patients have all the information they need to successfully navigate their cancer journey. But what happens when language barriers inhibit the flow of information between patient and practitioner? 

    April 25, 2019
    ONS Congress

    Safety Is Key in Use of Radiopharmaceuticals

    Radiopharmaceuticals, or radioactive drugs, are playing an increasing role in cancer diagnosis and treatment and thus are an increasingly relevant area of practice for oncology nurses, Paul Searfoss, BS, CNMT, ARRT (N, CT), of Vanderbilt Medical Center in Nashville, TN, said during a session on Saturday, April 13, 2019, at the ONS 44th Annual Congress in Anaheim, CA.

    April 13, 2019
    ONS Congress

    Good Documentation Is a Nurse’s Best Defense

    Good documentation is the best defense a nurse can have in the event of a lawsuit. This was the take-home message of a presentation by Joann Wortham, MSN, JD, CPHQ, CPPS, CPHRM, of Beta Healthcare Group in Alamo, CA, a large provider of professional liability insurance for hospitals, and Cyndi Maag, RN, BA, LNCC, of Eckenrode-Maupin, a legal practice in St. Louis, MO, during a session on Saturday, April 13, 2019, at the ONS 44th Annual Congress in Anaheim, CA.

    April 13, 2019
    ONS Congress

    Safe Handling of Hazardous Drugs Is No Accident

    Oncology nurses must remain vigilant to protect patients and themselves from chemotherapy exposure. During a session on Friday, April 12, 2019, at the ONS 44th Annual Congress in Anaheim, CA, Martha Polovich, PhD, RN, AOCN®, of Georgia State University in Atlanta, and MiKaela Olsen, APRN-CNS, MS, AOCNS®, FAAN, of Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, instructed nurses on how to ensure safe handling of hazardous drugs (HDs) in their practice settings.

    April 12, 2019
    ONS Congress

    Speakers Discuss Strategies for Reducing Workplace Violence

    Workplace violence is both highly prevalent and underreported in health care settings, according to Melissa Weigel, RN, and Lorina Welper, APRN, CNS, MS, of the Mayo Clinic in Rochester, MN, who spoke during a session on Friday, April 12, 2019, at the ONS 44th Annual Congress in Anaheim, CA.

    April 12, 2019
    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
    Adverse events

    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them

    As the use of oxaliplatin in the treatment of gastrointestinal, gynecologic, and other cancers continues to grow, so too does the incidence of hypersensitivity reactions connected to the drug. Because the development of HSRs may require patients to discontinue oxaliplatin even if it’s effective against their cancer, oncology nurses need to be able to prevent or minimize reactions whenever possible.

    April 09, 2019
    Joint Commission Focuses on Quality, Safety for 2019
    Safety

    Joint Commission Focuses on Quality, Safety for 2019

    As part of its ongoing work “to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating healthcare organizations and inspiring them to excel in providing safe and effective care of the highest quality and value,” the Joint Commission hosts an annual Health Care Association Forum to educate associations about the commission’s latest initiatives and goals. Here are the outcomes that affect nursing practice in 2019.

    March 27, 2019
    Evidence Doesn’t Support Antioxidant Supplementation for Patients With Cancer
    Complementary therapy

    Evidence Doesn’t Support Antioxidant Supplementation for Patients With Cancer

    Reactive oxygen species (ROS), such as hydroxyl and superoxide radicals, singlet oxygen, and hydrogen peroxide, are byproducts of metabolic processes in the body and play an important role in regulating cell physiology and function. But uncontrolled ROS formation (oxidative stress) can result in DNA, protein, and lipid damage, which has been implicated in several diseases, including cancer. Antioxidants, produced endogenously or in supplemental form, function as ROS scavengers and inhibit oxidative stress. Popular antioxidants include vitamins C and E, selenium, beta carotene, lycopene, resveratrol, flavonoids, anthocyanins, and catechins. They are widely used to prevent cancer and its recurrence.

    March 15, 2019
    Which of the Following Should Not Be Recommended to Patients Taking Oral Antineoplastic Medication at Home?
    Patient Education

    Which of the Following Should Not Be Recommended to Patients Taking Oral Antineoplastic Medication at Home?

    Which of the Following Should Not Be Recommended to Patients Taking Oral Antineoplastic Medication at Home?

    A. Handwashing before and after handling the medication is important.

    B. Use a urinal or bedpan instead of a toilet to reduce the risk of contamination via body fluids.

    C. Keep oral antineoplastic drugs separate from other medications.

    D. Do not touch tablets or capsules with bare hands; wear disposable gloves.      

    March 15, 2019
    Nursing Workplace Violence; Aggressive Drug Pricing Legislation; Gottlieb Steps Down
    Safety

    Nursing Workplace Violence; Aggressive Drug Pricing Legislation; Gottlieb Steps Down

    Although nurses are the number one trusted profession in the United States for the past 18 years in a row, they’re not necessarily the most protected sector. Hostile workforce environments and exposure to hazardous chemicals are still a part of too many nurses’ daily lives. Recently, the U.S. House Education and Labor Committee held hearings on workforce safety to better understand the what nurses and other healthcare workers endure.

    March 11, 2019
    Hospital-Acquired Conditions Reduced by Nearly 1 Million From 2014–2017
    Clinical practice

    Hospital-Acquired Conditions Reduced by Nearly 1 Million From 2014–2017

    According to an Agency for Healthcare Research and Quality (AHRQ) analysis, the number of hospital-acquired conditions (HACs) reported in the United States dropped by 910,000 (13%) from 2014–2017. 

    March 06, 2019
    Do Cytotoxic Agents Impact Ground Soil or Well Water?
    Safety

    Do Cytotoxic Agents Impact Ground Soil or Well Water?

    When patients go home after receiving their regimen of powerful cytotoxic agents, oncology nurses routinely encourage them to double flush after using the bathroom to ensure that trace amounts of hazardous medication are eliminated from the environment to prevent other members of the household from being exposed. But what happens with chemotherapy chemicals found in human waste as they enter a patient’s septic system—and eventually the water supply?

    January 16, 2019
    ONS Responds to 2019 ASCO Safe Handling Standards
    Press Releases

    ONS Safe Handling Guidelines Are Consistent With National Recommendations

    Last week, the American Society of Clinical Oncology (ASCO) released its 2019 safe handling standards. Although oncology nurses contributed to the expert panel, ONS does not endorse the ASCO standards because they differ from ONS guidelines and recommendations and guidelines from national and governmental organizations in several key ways. As an oncology nurse administering hazardous drugs, here’s what you need to know to keep yourself, your colleagues, and your patients safe.

    January 14, 2019
    JADPRO Live

    Action Plan May Reduce CLABSIs in Hospitalized Patients With Cancer

    Despite being preventable, central line-associated bloodstream infections (CLABSIs) result in thousands of deaths each year and cost the U.S. healthcare system billions of dollars. Infection is a common problem in patients with cancer, particularly those receiving chemotherapy and radiation.

    November 13, 2018
    How Oncology Nurses Support Non-Oncology Units Administering Chemotherapy
    Safety

    How Oncology Nurses Support Non-Oncology Units Administering Chemotherapy

    Most patients and practitioners associate chemotherapy with cancer treatments, yet the drugs are also used to treat a number of autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, antineutrophil cytoplasmic antibody–associated vasculitis, and systemic lupus erythematosus. 

    October 23, 2018
    Monitoring Surface Contamination of Hazardous Drugs and Considerations for Remediation
    Safe handling

    Monitoring Surface Contamination of Hazardous Drugs and Considerations for Remediation

    Hazardous drugs are medications known to cause adverse health effects because of exposure in the workplace, according to the National Institute for Occupational Safety and Health. Examples of such agents include chemotherapy drugs, antivirals, hormones, and bioengineered drugs.

    October 18, 2018
    drug spill safe handling
    Safe handling

    Which of the Following Drug Spills Doesn’t Require a Full-Facepiece, Chemical Cartridge-Type Respirator or PAPR?

    Which of the following drug spills doesn’t require a full-facepiece, chemical cartridge-type respirator or PAPR during clean up?

    A. 5-Fluorouracil 

    B. Cyclophosphamide 

    C. Adriamycin  

    D. Nitrogen mustard 

    July 26, 2018
    What Happens if Patients With Cancer Have Bedbugs?
    Safety

    What Happens if Patients With Cancer Have Bedbugs?

    Lurking in the dark corners of bedrooms across the country, unseen figures wait to feast of the blood of humans and animals alike. When the lights go dark, they come out for dinner. No, they’re not vampires or mystical beasts—they’re bedbugs. These parasitic insects feed exclusively on the blood of humans and animals and are a prevalent parasite in the United States. 

    July 19, 2018
    Verbal Abuse Is Still Violence, Joint Commission Says
    Incivility in nursing

    Verbal Abuse Is Still Violence, Joint Commission Says

    Healthcare workers, especially nurses, are less likely to report incidents of workplace violence, including verbal abuse from patients, families, and coworkers, according to a sentinel event alert the Joint Commission released in April.

    June 20, 2018
    ASCO Annual Meeting

    Organizational Learning and Perception Tied to Improved Patient Safety Culture

    Patient safety is an important focus for hospitals: protecting patients improves outcomes and quality of care, meets standards, and ensures payments and reimbursement. But what factors contribute to a culture of safety? Researchers assessed and analyzed the components of patient safety culture and published their study findings in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting.

    May 29, 2018
    ONS Congress

    Nurse-Led Initiatives Are Improving Patient Safety

    During a session at the 43rd Annual Congress in Washington, DC, various speakers discussed the latest findings in patient safety.

    May 19, 2018
    What’s the Preferred Method for Vincristine Administration When Treating a Patient With Lymphoma or Leukemia?
    Chemotherapy

    What’s the Preferred Method for Vincristine Administration When Treating a Patient With Lymphoma or Leukemia?

    What is the preferred method to administer vincristine into a peripheral IV site when treating a patient with lymphoma or leukemia? 

    A. Direct IV push by syringe 

    B. By syringe through free-flowing IV fluids (side-arm technique) 

    C. Gravity drip using an IV minibag 

    D. By minibag using an IV pump 

    May 10, 2018
    Which Is Not an ASCO/ONS Chemotherapy Safety Standard?
    Chemotherapy

    Which Is Not an ASCO/ONS Chemotherapy Safety Standard?

    Which of the following is NOT an ASCO/ONS Chemotherapy Administration Safety Standard?

    A. Chemotherapy orders include sequencing of agents, when applicable.  

    B. A licensed independent practitioner is on-site and readily available to staff where chemotherapy is administered.

    C. Two chemotherapy-competent RNs must be in the infusion area at all times when chemotherapy is infusing.  

    D. If chemotherapy is administered in a non-healthcare setting, a second identifier such as a driver’s license, is used to verify the patient’s identity.  

    April 19, 2018
    Supporting Second Victims Will Make Your Practice Safer
    Safety

    Supporting Second Victims Will Make Your Practice Safer

    Adverse events and traumatic moments send shockwaves through the entire care team. As families grieve the loss of a loved one, providers can often suffer from feelings of overwhelming guilt, remorse, or helplessness. When clinicians struggle with the aftermath of a tragic care event, they become known as second victims. Second victim experiences can lead to lapses in safety and care and could be potentially dangerous for future patients.

    April 12, 2018
    • First page « First
    • Previous page
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • ONS Congress Newscast
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲